Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KMO | O15229 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25823003 | 0.87 | L3MBTL1 (0.44) | TDP1L3MBTL1KMOADORA3ADORA2A | |
| SCHEMBL19622709 | 0.78 | MAPT (0.41) | TDP1L3MBTL1 | |
| SCHEMBL25823054 | 0.77 | S1PR1 (0.44) | TDP1L3MBTL1KMOADORA3ADORA2A | |
| SCHEMBL26360651 | 0.76 | MEN1 (0.35) | L3MBTL1KMOADORA3ADORA2AADORA1 | |
| SCHEMBL27250153 | 0.76 | GPR55 (0.34) | L3MBTL1ADORA3ADORA2AADORA1 | |
| SCHEMBL23959647 | 0.75 | L3MBTL1 (0.53) | TDP1L3MBTL1KMOADORA3ADORA2A | |
| SCHEMBL25822998 | 0.75 | L3MBTL1 (0.53) | TDP1L3MBTL1KMOADORA3ADORA2A | |
| SCHEMBL23959648 | 0.75 | L3MBTL1 (0.53) | TDP1L3MBTL1KMOADORA3ADORA2A | |
| SCHEMBL23959741 | 0.74 | TDP1 (0.49) | TDP1L3MBTL1KMOADORA3ADORA2A | |
| SCHEMBL13262321 | 0.73 | L3MBTL1 (0.44) | L3MBTL1ADORA3ADORA2AADORA1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225202-A1 | CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225202-A1 | CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | CRY1, CRY2, PER2 | TDP1 3027/4885L3MBTL1 1424/4885KMO 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.